Paradigm Biopharmaceuticals: Director Increases Shareholdings
Company Announcements

Paradigm Biopharmaceuticals: Director Increases Shareholdings

Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.

Paradigm Biopharmaceuticals Ltd. announced a significant change in the shareholdings of Director Paul Rennie, who now holds a total of 20,924,105 fully paid ordinary shares. The changes were facilitated through his ownership in KZEE Pty Ltd and EAR Investments Pty Ltd, reflecting a substantial interest in the company’s securities.

For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharma Advances Phase 3 Trials Amid Financial Prudence
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Advances Phase 3 Trial Plans
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Plans New Securities Issuance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App